Thanks Jack. I really mean it.
Oh wait I know the answer to that already. My bad.
Please don't be like Jack! Retail investors are always in the dark when it comes to Arena. Don't be like Jack! What deal did they turn down and why is that material event not public information?
More details please. Retail investors always in the dark. Don't be like Jack. Give us retail investors a helping hand. Don't be like Jack.
Up 60 cents now struggling to hold 20 cents. 40 cent gain evaportated. Thanks Jack! You are always one to follow through.
That is what I've been saying all along. Arena should be at $12 right now when compared to peers.
Shorts have been getting their way with this stock for 18 years as has Jack and Cindy.
We can only dream. I continue to hold and wish Jack would right every wrong in his forsaken career as CEO.
I'm all for $40 and yes it is possible as seen in RCPT and ACAD but with Jack at the helm this stock is going nowhere. The man isn't capable of transforming Arena into the R&D pharma we all know it could be. Wrong as CEO. Wrong as CFO. Wrong as CMO. Right as RIP.
Ummm. RCPT moves from $25 to $225 for a reason. In the same period ARNA falls from $13 to $4 for a reason. What is the reason pray tell?
It will take $1 billion and about 5 years to come to market. Period. That's if the trials are successful. Jack will be a ripe 75 years old!
Jack is a fool extraordinaire in choosing to proceed with ADP-356 vs. APD-334. He is worthy of the CEO and CFO position and needs to work until he is dirt. After all, age 70 is the new 50, right?